You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Messenger RNA

Showing 26 - 50 of 1,867
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)

Active, not recruiting
  • COVID-19
  • Tozinameran - Standard dose
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital
Aug 24, 2022

COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

Not yet recruiting
  • COVID-19
  • Tozinameran
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022

Cystic Fibrosis Trial in Christchurch (ARCT-032, Placebo)

Not yet recruiting
  • Cystic Fibrosis
  • Christchurch, New Zealand
    New Zealand Clinical Research
Feb 3, 2023

MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy

Not yet recruiting
  • Drug Resistant Epilepsy
  • MiRNA223 and High mobility group box1(HMGB1)
  • (no location specified)
Oct 16, 2022

Respiratory Syncytial Virus Trial in Panama, United States (mRNA-1345, Placebo)

Not yet recruiting
  • Respiratory Syncytial Virus
  • mRNA-1345
  • Placebo
  • Banning, California
  • +20 more
Oct 18, 2023

Prostate Cancer, Resistance, Disease, MicroRNAs Trial in Tours (Blood sample)

Recruiting
  • Prostate Cancer
  • +2 more
  • Blood sample
  • Tours, France
    CANCEL
May 17, 2022

Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 4 Trial in Rochester (Sulforaphane (Avmacol Extra Strength),

Not yet recruiting
  • Chronic Kidney Disease Stage 3
  • Chronic Kidney Disease Stage 4
  • Sulforaphane (Avmacol Extra Strength)
  • Placebo
  • Rochester, New York
    University of Rochester Medical Center
Apr 4, 2023

Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia

Not yet recruiting
  • Sickle Cell Disease, Beta Thalassemia Intermedia
  • RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
  • (no location specified)
May 30, 2023

Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)

Not yet recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 4, 2023

Bipolar Disorder Trial (MRI exam)

Not yet recruiting
  • Bipolar Disorder
  • MRI exam
  • (no location specified)
Dec 21, 2022

Chronic Kidney Diseases, COVID-19 Trial in Scarborough, Toronto (Pfizer-BioNTech COVID-19 Vaccine, MODERNA SARS-CoV-2 Vaccine)

Active, not recruiting
  • Chronic Kidney Diseases
  • COVID-19
  • Pfizer-BioNTech COVID-19 Vaccine
  • MODERNA SARS-CoV-2 Vaccine
  • Scarborough, Ontario, Canada
  • +2 more
Aug 5, 2022

Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a) Trial (SLN360, Placebo)

Not yet recruiting
  • Cardiovascular Diseases
  • +2 more
  • (no location specified)
Sep 12, 2022

Cytomegalovirus Infection Trial in North Hollywood, San Diego, Honolulu (mRNA-1647, Placebo)

Active, not recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • North Hollywood, California
  • +2 more
Dec 3, 2022

Psychosis Trial in France (behavioral, drug, other)

Not yet recruiting
  • Psychosis
  • Cognitive training
  • +2 more
  • Brest, France
  • +12 more
Mar 29, 2023

Obesity Trial in Lillehammer (Resistance exercise, Omega-3, Placebo)

Active, not recruiting
  • Obesity
  • Resistance exercise
  • +2 more
  • Lillehammer, Norway
    Inland Norway University of Applied Sciences
Aug 8, 2022

Lyme Disease Trial in United States (mRNA-1975, mRNA-1982, Placebo)

Recruiting
  • Lyme Disease
  • mRNA-1975
  • +2 more
  • Milford, Connecticut
  • +19 more
Jul 26, 2023

Influenza, Human Trial (Flu mRNA, Control 1, Control 2)

Not yet recruiting
  • Influenza, Human
  • Flu mRNA
  • +2 more
  • (no location specified)
Apr 21, 2023

COVID-19 Trial in Bizerte, Ariana, Tunis (CoronaVac/CoronaVac, CoronaVac/BNT162b2)

Completed
  • COVID-19
  • CoronaVac/CoronaVac
  • CoronaVac/BNT162b2
  • Bizerte, Mateur, Tunisia
  • +4 more
Jan 4, 2023

Soy Exposure on Bone Development and Gut Microbiota

Not yet recruiting
  • Child Development
  • No intervention is involved
  • (no location specified)
Jul 18, 2022

Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Fluzone HD)

Not yet recruiting
  • Respiratory Syncytial Virus
  • Placebo
  • +2 more
  • Scottsdale, Arizona
  • +32 more
Sep 23, 2023

Anti COVID-19 Vaccination Campaign Addressed to Employees

Completed
  • COVID-19
  • BNT162b2 COVID-19 Vaccine
  • Roma, RM, Italy
    Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Mar 15, 2023

Qualitative Features of Atherosclerotic Plaques

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • Riga, Latvia
    Pauls Stradins Clinical University Hospital
Dec 5, 2022

Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +

Recruiting
  • Myocardial Infarction
  • +2 more
  • P2Y12 Potent Inhibitor + Aspirin for STEMI patients
  • Clopidogrel + Aspirin for CCS patients
  • Messina, Italy
    AOU Policlinico G. Martino
Jan 21, 2023

Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)

Active, not recruiting
  • Influenza, Human
  • GSK4382276A Dose level 1
  • +4 more
  • Edegem, Belgium
  • +6 more
Jan 9, 2023

Rheumatoid Arthritis Trial in Sakarya (exercise, gene expressions of miRNA)

Completed
  • Rheumatoid Arthritis
  • exercise
  • gene expressions of miRNA
  • Sakarya, Turkey
    Sakarya Training and Research Hospital
Jun 13, 2023